BAY-3827
BAY-3827 : ATP competitive inhibitor of PRKAA1 and RPS6KA1
Structure
In Cells
In Model Organisms
SERP ratings and comments
SERP Ratings
(last updated: 3 Aug 2020 )
SERP Ratings
SERP Comments:
AMPK is an important kinase in energy metabolism and regulation, yet there is no reported quality tool compounds beside BAY-3827. The compound demonstrates cellular target engagement by inhibiting phosphorylation of ACC1 on Ser79. The compound is also quite selective when tested at 1 μM concentration against 331 kinases at 10 μM ATP. Nevertheless, it does carry off-target activities against RSK1/2/3/4 - when measured in Eurofins radioactive kinase assays at 10 μM ATP, the IC50 values for RSK1/2/3/4 and MSK1 (RPS6KA5) are within ~5-fold of reported values for AMPKα1 and AMPKα2. Without data comparing the potency of BAY-3827 against AMPK and RSK1/2/3/4 at physiological concentration of 1 mM ATP (or in cellular mechanistic assays), the exact fold selectivity is difficult to assess. Given the lack of parallel tool compounds also targeting AMPK from alternative chemical scaffolds, one may consider use of selective RSK1/2/3/4 inhibitors, for example LJH685 or LJI308, as control for any cellular effects due to RSK1/2/3/4 inhibition.
(last updated: 24 Mar 2021 )
SERP Ratings
(last updated: 22 Mar 2023 )